Mr Sirus Hamzavi, MD | |
15 Lowell St, Portland, ME 04102-2726 | |
(207) 774-8277 | |
(207) 871-1415 |
Full Name | Mr Sirus Hamzavi |
---|---|
Gender | Male |
Speciality | Ophthalmology |
Experience | 32 Years |
Location | 15 Lowell St, Portland, Maine |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1174503825 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207W00000X | Ophthalmology | 016330 (Maine) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Maine General Medical Center | Augusta, ME | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Mainegeneral Medical Center | 1254245715 | 487 |
News Archive
Children with asthma living in multi-family housing who are exposed to certain levels of indoor nitrogen dioxide, a poisonous pollutant byproduct of gas stoves and unvented heaters, are more likely to experience wheeze, persistent cough, shortness of breath and chest tightness.
For patients with undiagnosed heart disease, taking medications known as statins and beta-blockers may mean the difference between suffering a heart attack as a first symptom versus experiencing mild chest pain.
Forty per cent of older adults who leave hospital are discharged to home care or a long-term care facility, which, combined with where they lived before hospitalization, affects their risk of readmission, found a study published in CMAJ.
Accretive Health, Inc., a leading provider of end-to-end revenue cycle management services for U.S. healthcare providers, today announced it has closed its previously announced initial public offering of 11,500,000 shares of its common stock at a price to the public of $12.00 per share.
Protalix BioTherapeutics, Inc. has announced that it has received written notice from the United States Food and Drug Administration (FDA) that it may initiate a Phase III clinical trial in the United States of its lead product candidate, prGCD, a proprietary plant cell expressed recombinant form of human Glucocerebrosidase (GCD), for the treatment of Gaucher Disease, a lysosomal storage disorder in humans.
› Verified 3 days ago
Entity Name | Mainegeneral Medical Center |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1669423380 PECOS PAC ID: 1254245715 Enrollment ID: O20031118000718 |
News Archive
Children with asthma living in multi-family housing who are exposed to certain levels of indoor nitrogen dioxide, a poisonous pollutant byproduct of gas stoves and unvented heaters, are more likely to experience wheeze, persistent cough, shortness of breath and chest tightness.
For patients with undiagnosed heart disease, taking medications known as statins and beta-blockers may mean the difference between suffering a heart attack as a first symptom versus experiencing mild chest pain.
Forty per cent of older adults who leave hospital are discharged to home care or a long-term care facility, which, combined with where they lived before hospitalization, affects their risk of readmission, found a study published in CMAJ.
Accretive Health, Inc., a leading provider of end-to-end revenue cycle management services for U.S. healthcare providers, today announced it has closed its previously announced initial public offering of 11,500,000 shares of its common stock at a price to the public of $12.00 per share.
Protalix BioTherapeutics, Inc. has announced that it has received written notice from the United States Food and Drug Administration (FDA) that it may initiate a Phase III clinical trial in the United States of its lead product candidate, prGCD, a proprietary plant cell expressed recombinant form of human Glucocerebrosidase (GCD), for the treatment of Gaucher Disease, a lysosomal storage disorder in humans.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Mr Sirus Hamzavi, MD 15 Lowell St, Portland, ME 04102-2726 Ph: (207) 774-8277 | Mr Sirus Hamzavi, MD 15 Lowell St, Portland, ME 04102-2726 Ph: (207) 774-8277 |
News Archive
Children with asthma living in multi-family housing who are exposed to certain levels of indoor nitrogen dioxide, a poisonous pollutant byproduct of gas stoves and unvented heaters, are more likely to experience wheeze, persistent cough, shortness of breath and chest tightness.
For patients with undiagnosed heart disease, taking medications known as statins and beta-blockers may mean the difference between suffering a heart attack as a first symptom versus experiencing mild chest pain.
Forty per cent of older adults who leave hospital are discharged to home care or a long-term care facility, which, combined with where they lived before hospitalization, affects their risk of readmission, found a study published in CMAJ.
Accretive Health, Inc., a leading provider of end-to-end revenue cycle management services for U.S. healthcare providers, today announced it has closed its previously announced initial public offering of 11,500,000 shares of its common stock at a price to the public of $12.00 per share.
Protalix BioTherapeutics, Inc. has announced that it has received written notice from the United States Food and Drug Administration (FDA) that it may initiate a Phase III clinical trial in the United States of its lead product candidate, prGCD, a proprietary plant cell expressed recombinant form of human Glucocerebrosidase (GCD), for the treatment of Gaucher Disease, a lysosomal storage disorder in humans.
› Verified 3 days ago
Scott M Steidl, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 53 Sewall Street, Portland, ME 04102 Phone: 207-828-2020 Fax: 207-773-7034 | |
Linda K Morrison, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 331 Veranda St, Portland, ME 04103 Phone: 207-828-2402 Fax: 207-872-8242 | |
Robert S Cady, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 15 Lowell St, Portland, ME 04102 Phone: 207-774-8277 Fax: 207-699-5850 | |
Robert W Daly, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 53 Sewall St, Portland, ME 04102 Phone: 207-828-2020 Fax: 207-773-7034 | |
Nathaniel R Gelinas, D.O. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 15 Lowell St, Portland, ME 04102 Phone: 207-774-8277 Fax: 207-523-5310 | |
Curtis Mackay Libby, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 15 Lowell St, Portland, ME 04102 Phone: 207-774-8277 Fax: 207-699-5850 |